Xenon Xe 133 Gas
"The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ("...
Xenon Xe 133 Gas
Xenon Xe 133 Gas Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Xenon Xe 133 Gas is a diagnostic agent used to evaluate pulmonary function and to image the lungs. It may also be applied to assessment of cerebral flow. Side effects are uncommon; consult your doctor.
The suggested activity range of Xenon Xe 133 Gas employed for inhalation by the average adult patient (70 kg) is: Pulmonary function including imaging: 74-1110 MBq (2-30 mCi) in 3 liters of air. Cerebral blood flow: 370-1110 MBq (10-30 mCi) in 3 liters of air. Xenon Xe 133 Gas may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Xenon Xe 133 Gas should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Xenon Xe 133 Gas Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Xenon Xe 133 Gas FDA Prescribing Information: Side Effects
Additional Xenon Xe 133 Gas Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.